Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pregnancy
Biotech
Ferring terminates fertility trials after ‘portfolio assessment’
Two trials testing the pairing of choriogonadotropin beta with Rekovelle have been terminated as part of “a broader portfolio assessment.”
Darren Incorvaia
Apr 2, 2026 2:00pm
Fierce Healthcare
Judge sides with states, blocking HHS reorg and mass layoffs
Jul 1, 2025 3:30pm
Fewer than 1% of trials include pregnant patients, study finds
Jan 29, 2025 2:06pm
Testmaker BillionToOne claims $1B valuation with $130M round
Jun 26, 2024 9:54am
FDA OKs artificial pancreas app for pregnant women with diabetes
May 28, 2024 12:00pm
Labcorp unveils first-trimester blood test for preeclampsia risk
May 21, 2024 2:30pm